Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis
- PMID: 15352124
- DOI: 10.1002/mc.20039
Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis
Abstract
The rate-limiting enzyme for mevalonate synthesis in mammalian cells is 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. Products of mevalonate synthesis are required for cell cycle progression as well as cell growth and survival. In tumor cells, HMG-CoA reductase is generally elevated because of attenuated sterol-mediated regulation of transcription. However, tumor cell HMG-CoA reductase remains sensitive to post-transcriptional regulation by mevalonate-derived isoprenoid intermediates of cholesterol synthesis. Isoprenoids suppress HMG-CoA reductase synthesis through a mechanism that reduces initiation of translation on HMG-CoA reductase mRNA. Because HMG-CoA reductase mRNA transcripts have 5'-untranslated regions (UTR) that are GC rich and contain stable secondary structure, we tested the hypothesis that overexpression of eIF4E would attenuate isoprenoid-mediated regulation of HMG-CoA reductase. eIF4E is elevated in many tumor cells and behaves as a proto-oncogene by aberrantly translating mRNAs whose translation is normally suppressed by 5-UTRs that are GC rich. A CHO cell line expressing high levels of eIF4E (rb4E) was developed by infecting cells with retroviruses containing a full-length mouse cDNA for eIF4E. Levels of reductase synthesis were elevated fivefold in rb4E cells compared to noninfected CHO cells; HMG-CoA reductase mRNA levels were not increased in rb4E cells compared to normal CHO cells. Total cellular protein synthesis was only increased by approximately 15% in rb4E cells compared to CHO cells. The mTOR inhibitor rapamycin lowered HMG-CoA reductase synthesis by 50 and 60% in rb4E and CHO cells, respectively; no equivalent effect was observed for HMG-CoA reductase mRNA levels with rapamycin treatment. These results indicate that HMG-CoA reductase mRNA is in a class of mRNAs with highly structured 5'-UTRs whose m(7)GpppX cap-dependent translation is closely linked to the rapamycin-sensitive mitogen activated pathway for protein synthesis.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.Arch Biochem Biophys. 1995 Feb 20;317(1):235-43. doi: 10.1006/abbi.1995.1158. Arch Biochem Biophys. 1995. PMID: 7872789
-
The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate.Arch Biochem Biophys. 1995 Oct 1;322(2):475-85. doi: 10.1006/abbi.1995.1491. Arch Biochem Biophys. 1995. PMID: 7574724
-
Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.J Nutr. 2003 Jan;133(1):38-44. doi: 10.1093/jn/133.1.38. J Nutr. 2003. PMID: 12514264
-
Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.Exp Biol Med (Maywood). 2004 Jul;229(7):567-85. doi: 10.1177/153537020422900701. Exp Biol Med (Maywood). 2004. PMID: 15229351 Review.
-
[The key enzyme of cholesterol synthesis pathway: HMG-CoA reductase and disease].Sheng Li Ke Xue Jin Zhan. 1999 Jan;30(1):5-9. Sheng Li Ke Xue Jin Zhan. 1999. PMID: 12532841 Review. Chinese.
Cited by
-
Disruption of an hTERT-mTOR-RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin.Mol Cell Biochem. 2013 Mar;375(1-2):97-104. doi: 10.1007/s11010-012-1532-3. Epub 2013 Jan 3. Mol Cell Biochem. 2013. PMID: 23283642
-
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):267-76. doi: 10.1007/s00005-008-0027-0. Epub 2008 Jul 29. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18726148 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous